Author: G31 Admin

New Offering: G31’s Conference Impact Sprint

Real results. Fast turnaround.

Conference season is around the corner, and for most life sciences companies, the stakes are high. Whether you’re preparing for your next booth or trying to stand out without one, the right strategy can mean the difference between casual chats and actual growth. 

That’s why Group 31 Communications is launching our Conference Impact Sprint: a fast-turn, done-with-you package designed to help pharma, biotech, device, and diagnostic companies get real results from upcoming conferences. 

The Sprint: A faster path to conference wins 

The Conference Impact Sprint is built for teams who don’t have months to figure it out—and don’t want to waste money guessing. 

In just a few weeks, Group 31 will help you: 

  • Map out your pre-, during-, and post-conference strategy 
  • Sharpen your messaging to drive conversations that matter 
  • Optimize your materials quickly (even if your team is already stretched) 
  • Build a lead follow-up plan that closes deals 

Optional creative support is available for teams that need design, social content, or additional execution help. 

Discuss the Sprint 

Not ready for a full Sprint? Start with the Checklist. 

For companies that need to start smaller (for whatever reason, no judgment here), Group 31 is also offering 2 free Conference Impact Checklists, one for those with a booth and one for those without. It’s a self-guided tool to help you make the most of your next event. Walk in with confidence whether you’re working the booth or flying solo.

Choose a Checklist 

Let’s get started

If you’re ready to turn conference season into real business growth, start here. You’ll choose the option that fits your goals and timeline. This is your season.  

About Group 31 Communications

Group 31 Communications is a full-service healthcare marketing agency that specializes in supporting emerging and midsized pharmaceutical companies with their medical education and marketing needs. Founded in 2010, Group 31 has successfully partnered with preclinical companies, launch brands, and legacy brands by integrating with clients’ medical and marketing teams to uncover challenges and sculpt strategic solutions.

Contact Information

Crystal Weber, CEO
919.481.0822
[email protected]

Make Your CRM Work for You: Insights From Our NCBiotech Webinar

Customer relationship management (CRM) systems can be powerful tools when used strategically. Recently, Group 31 Communications CEO Crystal Weber was invited to present a webinar for NCBiotech on optimizing CRM strategies for biotech and life sciences companies. While preparing, she realized something: if you approach your CRM like a science experiment, it can completely change how you engage with investors, key opinion leaders (KOLs), and partners.

Key highlights: 

  1. Approach CRM Like a Science Experiment

Test, analyze, refine. Your CRM is your lab, your email is the intervention, and engagement is the effect. Instead of treating the CRM as a static database, track interactions like a scientist looking for patterns:

  • Who’s responding? Who isn’t?
  • Which messages spark interest? Which get ignored?

For those who aren’t engaging, shift them into a lower-touch, automated nurture stream to stay on their radar without heavy effort. For those who do engage, double down with personalized follow-ups to build momentum.

  1. Segment, Then Sub-Segment

Not all contacts need the same updates. Segment your CRM based on your contacts’ relationships with you—investors, KOLs, partners—and then take it a step further:

  • Potential investors need different information than current investors or those already in your data room
  • Early-stage KOLs require a different approach than long-term collaborators
  • Partners may be the widest-ranging group and may include people like vendors or R&D collaborators, each with their own information needs

By sub-segmenting, you can automate tailored messaging and schedule strategic follow-ups without overloading your team or your contacts.

  1. Automate Without Losing the Human Touch

Automation is a game-changer, but only if it still feels personal. Use your CRM to:

  • Schedule reminders so nothing falls through the cracks
  • Trigger follow-ups at key moments
  • Standardize email templates while keeping room for personal touches (like referencing past conversations)

The goal is efficiency without sounding robotic.

  1. Think Beyond Business Development

Your CRM isn’t just for BD. Multiple teams—BD, medical affairs, regulatory, leadership—often interact with the same external stakeholders. A well-integrated CRM prevents redundant outreach and ensures consistent messaging across teams.

  1. Data Hygiene = Future Success

A messy CRM is an ineffective one. Keep it clean and functional by:

  • Assigning a CRM champion to oversee best practices
  • Standardizing data entry (naming conventions, contact updates)
  • Scheduling regular cleanups to remove outdated or duplicate contacts

A well-maintained CRM ensures your team can trust the information they rely on for high-stakes conversations and decisions.

Need Help Implementing These Strategies?

If these ideas sound valuable but implementing them feels overwhelming, we can help. Whether it’s setting up a new CRM, refining your workflows, or optimizing automation, we’ll make your CRM work for you.

Let’s chat. Contact us today.

About Group 31 Communications

Group 31 Communications is a full-service healthcare marketing agency that specializes in supporting emerging and midsized pharmaceutical companies with their medical education and marketing needs. Founded in 2010, Group 31 has successfully partnered with preclinical companies, launch brands, and legacy brands by integrating with clients’ medical and marketing teams to uncover challenges and sculpt strategic solutions.

Contact Information

Crystal Weber, CEO
919.481.0822
[email protected]

5 Key Takeaways for Reducing Risk in Pharma Marketing

Group 31 CEO Crystal Weber recently appeared on the podcast The Factor, by Kymanox, where she shared insights into how expert guidance can help biotech and pharma companies navigate regulations while delivering compelling marketing messages. Now we’re sharing 5 key takeaways from that interview.

  1. Start thinking about marketing yesterday. 

“The best time to start thinking about marketing is before you have a name for anything be thinking about marketing then and how you can proactively [keep] your company safe.” 

Marketing really begins pre-label, when you’re talking to investors. Look at marketing in the same vein as having a forward-looking statement in all of your presentations—you can be positive and excited, but you know there are still rules to follow. Start thinking about marketing, labeling, and regulatory expectations right from the start, even as you’re rolling your product out of your academic institution.

  1. Get the word out early. 

“The more often that people are talking and thinking about your brand, the better you’re going to be able to get your KOLs to know who you are when a potential investor calls them and says, ‘Hey, can you vet this science for me?’” 

Marketing starts with name recognition. And name recognition is built through exposure, which can be time-consuming and expensive. But with the right support, you can create effective marketing—within budget—that’s targeted exactly to the people you need to inform. 

  1. Stick to the facts. 

“Our job as scientists and science communicators is to tell the truth, which means making sure that you’re not overpromising, even if you’re really excited.” 

Best practice is to start by thinking about what’s right for the consumer—the patient—and work your way from there. Believe in your product, be realistic about the risks and benefits, and adhere to accuracy. Remember that you’re communicating with healthcare providers who believe in science and in protecting their patients. 

  1. Employ expert help. 

“If you can hand the regulatory piece of it off to people to help keep you safe, help protect the company, it’s like an insurance policy.” 

Keep your focus on developing the science and bringing your product to market—hand the regulatory piece of it off to experts who can help protect you and your company. When you’ve got a strong communications team around you, you can focus on the work and not have to worry about wordsmithing a marketing message that keeps you on the good side of the FDA.

  1. Find the company that’s the right fit for you.  

“If you’re very, very early stage, you don’t need to go to a huge, you know, Manhattan-based company. Those are great, but they are not going to be able to scale to your budget.” 

When you find a company that’s the right fit, they can help you grow. They’ll become part of your team and work with you to identify goals and prioritize projects that accomplish them cost-effectively. An agency that’s a true partner knows that when you succeed, they succeed.

We can put our insights and experience to work for you—let’s talk.

About Group 31 Communications

Group 31 Communications is a full-service healthcare marketing agency that specializes in supporting emerging and midsized pharmaceutical companies with their medical education and marketing needs. Founded in 2010, Group 31 has successfully partnered with preclinical companies, launch brands, and legacy brands by integrating with clients’ medical and marketing teams to uncover challenges and sculpt strategic solutions.

Contact Information

Crystal Weber, CEO
919.481.0822
[email protected]

MM+M Names Women of Distinction Honorees

Crystal Weber, of Group 31 in Raleigh, is being recognized for her ability to innovate and inspire

MM+M has announced its 2024 Women of Distinction and Women to Watch honorees. Now in their ninth year, the MM+M Women of Distinction and Women to Watch programs celebrate healthcare marketing executives who have significantly impacted their organizations — and the industry writ large — during the past year. 

Crystal Weber, CEO of Group 31 Communications in Raleigh, NC, has been selected as a Woman of Distinction. The honor showcases a dynamic group of women showcasing new and innovative ways of doing business, mentoring the women on their teams and creating a solid foundation of leaders for years to come. 

After 15 years as a healthcare provider, Crystal joined Group 31 in 2018. Beginning as Director of Medical Communications, Crystal served in progressively responsible roles, and in 2022 she was named CEO. At Group 31, her role combines her scientific expertise, award-winning writing, and creative marketing acumen.  

“For the ninth year in a row, we’re thrilled to be able to showcase the leaders whose creativity and spirit set the bar high, both internally and among their peers. We look forward to celebrating the achievements of the 2024 classes of Women of Distinction and Women to Watch,” said MM+M executive editor Larry Dobrow. 

The 2024 Women of Distinction and Women to Watch honorees will be celebrated at an in-person event scheduled for June 13 in New York City and were profiled in the May print edition of MM+M.

About Group 31 Communications

Group 31 Communications is a full-service healthcare marketing agency that specializes in supporting emerging and midsized pharmaceutical companies with their medical education and marketing needs. Founded in 2010, Group 31 has successfully partnered with preclinical companies, launch brands, and legacy brands by integrating with clients’ medical and marketing teams to uncover challenges and sculpt strategic solutions.

Contact Information

Crystal Weber, CEO
919.481.0822
[email protected]